Published in Health Qual Life Outcomes on December 04, 2007
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol (2011) 1.21
Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int (2009) 0.92
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. Neurol Sci (2012) 0.92
Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster. Local Reg Anesth (2010) 0.90
Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves. Local Reg Anesth (2012) 0.81
Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting. Clin Drug Investig (2013) 0.79
Clinical characteristics, patient-reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinics. Pain Res Treat (2014) 0.78
Validation of the Korean Version of the DN4 Diagnostic Questionnaire for Neuropathic Pain in Patients with Lumbar or Lumbar-Radicular Pain. Yonsei Med J (2016) 0.77
The reliability of the modified lower extremity functional scale among adults living with HIV on antiretroviral therapy, in Rwanda, Africa. SAHARA J (2014) 0.77
Validity and Reliability of a Novel Ocular Pain Assessment Survey (OPAS) in Quantifying and Monitoring Corneal and Ocular Surface Pain. Ophthalmology (2016) 0.75
Add-on treatment with pregabalin for patients with uncontrolled neuropathic pain who have been referred to pain clinics. Clin Drug Investig (2014) 0.75
Intrathecal Ziconotide and Morphine for Pain Relief: A Case Series of Eight Patients with Refractory Cancer Pain, Including Five Cases of Neuropathic Pain. Neurol Ther (2015) 0.75
Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. Trials (2017) 0.75
5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions. J Pain Res (2016) 0.75
Treatment of acute and chronic focal neuropathic pain in cancer patients with lidocaine 5 % patches. A radiation and oncology department experience. Support Care Cancer (2012) 0.75
Chronic abdominal syndrome due to nervous compression. Study of 100 cases and proposed diagnostic-therapeutic algorithm. J Gastrointest Surg (2015) 0.75
Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy. Brain (2017) 0.75
Hindi version of short form of douleur neuropathique 4 (S-DN4) questionnaire for assessment of neuropathic pain component: a cross-cultural validation study. Korean J Pain (2017) 0.75
Development and validation of Arabic version of the douleur neuropathique 4 questionnaire. Saudi J Anaesth (2017) 0.75
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09
The short-form McGill Pain Questionnaire. Pain (1987) 14.40
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain (2005) 4.59
The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain (2001) 3.90
The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain (2006) 3.67
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
EFNS guidelines on neuropathic pain assessment. Eur J Neurol (2004) 1.96
Development of a neuropathic pain questionnaire. Clin J Pain (2003) 1.96
Defining neuropathic pain. Anesth Analg (2003) 1.85
Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin (2006) 1.65
The clinical picture of neuropathic pain. Eur J Pharmacol (2001) 1.53
Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin (2006) 1.34
Sensitivity, specificity and predictive values: a graphical approach. Stat Med (1987) 1.15
Difficulties in stratifying neuropathic pain by mechanisms. Eur J Pain (2003) 0.98
[Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain]. Med Clin (Barc) (2006) 0.94
[Measurements of quality of life related with health. Basic concepts and cultural adaptation]. Med Clin (Barc) (2001) 0.88
Neuropathic pain and injured nerve: central mechanisms. Br Med Bull (1991) 0.87
[Prevalence of neuropathic pain in Spain: clinical, working and health care implications]. Med Clin (Barc) (2005) 0.84
Neuropathic pain: a crisis of definition? Anesth Analg (2003) 0.83
How do drugs relieve neurogenic pain? Drugs Aging (1997) 0.80
NeuPSIG guidelines on neuropathic pain assessment. Pain (2010) 4.04
Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain (2010) 2.16
Using screening tools to identify neuropathic pain. Pain (2006) 2.09
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord (2008) 1.97
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr Res (2006) 1.88
Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain (2010) 1.88
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry (2009) 1.61
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain (2013) 1.60
Antiinflammatory effect of peripheral nerve blocks after knee surgery: clinical and biologic evaluation. Anesthesiology (2008) 1.58
Antimuscarinic persistence patterns in newly treated patients with overactive bladder: a retrospective comparative analysis. Int Urogynecol J (2013) 1.57
Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain (2011) 1.55
Pharmacological dissection of the paradoxical pain induced by a thermal grill. Pain (2008) 1.55
Cognitive function impairment in patients with neuropathic pain under standard conditions of care. J Pain Symptom Manage (2007) 1.50
Small fibre impairment predicts neuropathic pain in Guillain-Barré syndrome. Pain (2010) 1.49
Who is healthy? Aspects to consider when including healthy volunteers in QST-based studies-a consensus statement by the EUROPAIN and NEUROPAIN consortia. Pain (2015) 1.47
High mortality in patients with influenza A pH1N1 2009 admitted to a pediatric intensive care unit: a predictive model of mortality. Pediatr Crit Care Med (2012) 1.45
Brain imaging of neuropathic pain. Neuroimage (2007) 1.25
Are psychological predictors of chronic postsurgical pain dependent on the surgical model? A comparison of total knee arthroplasty and breast surgery for cancer. J Pain (2013) 1.24
Usefulness and limitations of quantitative sensory testing: clinical and research application in neuropathic pain states. Pain (2007) 1.23
The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain (2011) 1.23
Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain (2004) 1.22
A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings. BMC Neurol (2011) 1.21
Translation to Portuguese and validation of the Douleur Neuropathique 4 questionnaire. J Pain (2009) 1.20
Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q). Value Health (2008) 1.18
Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness. BMC Infect Dis (2010) 1.18
The evolution of primary hyperalgesia in orthopedic surgery: quantitative sensory testing and clinical evaluation before and after total knee arthroplasty. Anesth Analg (2007) 1.17
Assessment of neuropathic pain in primary care. Am J Med (2009) 1.14
Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes (2010) 1.14
Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain (2006) 1.13
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res (2010) 1.09
Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study. Arthritis Res Ther (2009) 1.05
The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 Questionnaire. J Pain (2011) 1.05
Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty. Anesthesiology (2008) 1.03
Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord (2008) 1.03
Anatomical connections between brain areas activated during rectal distension in healthy volunteers: a visceral pain network. Eur J Pain (2009) 1.02
A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study. Schizophr Res (2008) 1.01
Psychophysical study of the effects of topical application of menthol in healthy volunteers. Pain (2006) 1.00
Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study. J Alzheimers Dis (2010) 0.99
Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain (2011) 0.98
Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disord (2010) 0.96
Neuropharmacological basis of rTMS-induced analgesia: the role of endogenous opioids. Pain (2010) 0.96
Towards a new taxonomy of idiopathic orofacial pain. Pain (2005) 0.95
[Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain]. Med Clin (Barc) (2006) 0.94
Alteration of cortical excitability in patients with fibromyalgia. Pain (2010) 0.94
Risk factors predictive of chronic postsurgical neuropathic pain: the value of the iliac crest bone harvest model. Pain (2012) 0.94
Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int (2009) 0.92
Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions. Eur J Pain (2006) 0.92
Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain (2015) 0.91
The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice. Health Qual Life Outcomes (2012) 0.91
Development and validation of the Migraine Screen Questionnaire (MS-Q). Headache (2005) 0.89
Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover study. J Support Oncol (2011) 0.88
Long-range hybrid network with point and distributed Brillouin sensors using Raman amplification. Opt Express (2010) 0.88
Conceptual adequacy of the neuropathic pain symptom inventory in six countries. Health Qual Life Outcomes (2008) 0.88
Neuropathic pain: an updated grading system for research and clinical practice. Pain (2016) 0.87
Diffuse analgesic effects of unilateral repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers. Pain (2009) 0.87
Using the WHOQOL-BREF in persons with dementia: a validation study. Alzheimer Dis Assoc Disord (2011) 0.86
Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination. BMC Musculoskelet Disord (2009) 0.85
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. Eur Neuropsychopharmacol (2011) 0.85
Prevalence and characterization of neuropathic pain in a primary-care setting in Spain: a cross-sectional, multicentre, observational study. Clin Drug Investig (2009) 0.85
Does cognitive functioning predict chronic pain? Results from a prospective surgical cohort. Brain (2014) 0.85
Breakthrough cancer pain - still a challenge. J Pain Res (2012) 0.85
[Adaptation and validation of the Health Utilities Index Mark 3 into Spanish and correction norms for Spanish population]. Med Clin (Barc) (2003) 0.85
Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans. Anesthesiology (2007) 0.85
New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care. BMC Neurol (2010) 0.84
Epidemiology of neuropathic pain: can we use the screening tools? Pain (2007) 0.84
Functional brain imaging of trigeminal neuralgia. Eur J Pain (2010) 0.84
[Prevalence of neuropathic pain in Spain: clinical, working and health care implications]. Med Clin (Barc) (2005) 0.84
Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia. Schizophr Res (2007) 0.84
The efficacy of a glial inhibitor, minocycline, for preventing persistent pain after lumbar discectomy: a randomized, double-blind, controlled study. Pain (2013) 0.83
All in one: is it possible to assess all dimensions of any pain with a simple questionnaire? Pain (2009) 0.83
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain. Clin Drug Investig (2006) 0.83
An economic analysis of pharmacological treatment of COPD in Spain. Respir Med (2009) 0.83
Disability and health-related quality of life in outpatients with generalised anxiety disorder treated in psychiatric clinics: is there still room for improvement? Ann Gen Psychiatry (2011) 0.83
A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain (2013) 0.83
Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use. Eur Addict Res (2011) 0.82
Effects of morphine on the experimental illusion of pain produced by a thermal grill. Pain (2008) 0.82
Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: a meta-analysis of randomized clinical trials. Rev Psiquiatr Salud Ment (2011) 0.82
The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study. Community Ment Health J (2012) 0.81
Pain management and pain characteristics in obese and normal weight patients before joint replacement. J Eval Clin Pract (2014) 0.81
Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: a decision-tree model. BMC Urol (2011) 0.81
WDM bi-directional transmission over 35 km amplified fiber-optic bus network using Raman amplification for optical sensors. Opt Express (2005) 0.81
Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings. Pain Med (2010) 0.81
Clinical, functional and structural determinants of central pain in syringomyelia. Brain (2010) 0.81
Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain (2002) 0.81
Length of stay and antipsychotic treatment costs of patients with acute psychosis admitted to hospital in Spain. Description and associated factors. The Psychosp study. Soc Psychiatry Psychiatr Epidemiol (2004) 0.81
Psychometric validation of the Portuguese version of the Neuropathic Pain Symptoms Inventory. Health Qual Life Outcomes (2011) 0.81
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective. Eur J Health Econ (2009) 0.81
Management and prognosis of acute liver failure in children. Curr Gastroenterol Rep (2012) 0.81
Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form. Clin Drug Investig (2012) 0.80
Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia. Schizophr Res (2012) 0.80
A confirmatory study of the Combined Index of Severity of Fibromyalgia (ICAF*): factorial structure, reliability and sensitivity to change. Health Qual Life Outcomes (2011) 0.80
Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction. J Clin Pharmacol (2009) 0.80
Comparison of wavelength-division-multiplexed distributed fiber Raman amplifier networks for sensors. Opt Express (2006) 0.80
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain. Eur J Health Econ (2004) 0.80
Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S). Schizophr Res (2009) 0.80
[Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV₁/FEV₆ for the diagnosis of COPD]. Med Clin (Barc) (2011) 0.80